Patient‐reported outcome measures in multiple myeloma: Real‐time reporting to improve care (My‐PROMPT) ‐ a pilot randomized controlled trial
Open Access
- 3 April 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (7), E178-E181
- https://doi.org/10.1002/ajh.25815
Abstract
No abstract availableFunding Information
- Gilead Australia Fellowship Research Grant
- Takeda Pharmaceuticals Australia Pty Ltd
This publication has 7 references indexed in Scilit:
- Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0BMC Cancer, 2018
- Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communicationSupportive Care in Cancer, 2017
- Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryBMC Medical Research Methodology, 2016
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled TrialJournal of Clinical Oncology, 2016
- Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)BMC Cancer, 2015
- Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized TrialJournal of Clinical Oncology, 2011
- Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trialJournal of the American Medical Informatics Association, 2010